Screener
National Health Investors NHI EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by National Health Investors in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: National Health Investors’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000877860-26-000135
| Line item | Three Months Ended / March 31, 2026 | 2025 |
|---|---|---|
| Less: Net income allocated to participating securities | (78) | (52) |
| Net income attributable to common stockholders | $40,024 | $34,113 |
| Weighted average common shares outstanding: | ||
| Basic | 48,323,945 | 45,720,496 |
| Diluted | 48,547,893 | 45,878,528 |
| Earnings per share: | ||
| Basic | $0.83 | $0.75 |
| Diluted | $0.82 | $0.74 |
Item 1. Financial Statements
FAQ
- What is National Health Investors's EPS (diluted)?
- National Health Investors (NHI) reported EPS (diluted) of $0.82 in Q1 2026.
- How has National Health Investors's EPS (diluted) changed year-over-year?
- National Health Investors's EPS (diluted) increased by 10.8% year-over-year, from $0.74 to $0.82.
- What is the long-term trend for National Health Investors's EPS (diluted)?
- Over 4 years (2021 to 2025), National Health Investors's EPS (diluted) has grown at a 5.6% compound annual growth rate (CAGR), from $2.43 to $3.02.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about National Health Investors's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude